BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 21883492)

  • 21. Peyronie's disease with erectile dysfunction: penile modeling over inflatable penile prostheses.
    Chaudhary M; Sheikh N; Asterling S; Ahmad I; Greene D
    Urology; 2005 Apr; 65(4):760-4. PubMed ID: 15833523
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors Associated With Erectile Dysfunction and the Peyronie's Disease Questionnaire in Patients With Peyronie Disease.
    Serefoglu EC; Smith TM; Kaufman GJ; Liu G; Yafi FA; Hellstrom WJG
    Urology; 2017 Sep; 107():155-160. PubMed ID: 28554517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Erectile function profiles in men with Peyronie's disease.
    Deveci S; Palese M; Parker M; Guhring P; Mulhall JP
    J Urol; 2006 May; 175(5):1807-11; discussion 1811. PubMed ID: 16600766
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of incision and saphenous vein grafting for Peyronie's disease on penile length and sexual satisfaction.
    Yurkanin JP; Dean R; Wessells H
    J Urol; 2001 Nov; 166(5):1769-72; discussion 1772-3. PubMed ID: 11586221
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of tunical defect size after Peyronie's plaque excision on postoperative erectile function: do centimeters matter?
    Kozacioglu Z; Degirmenci T; Gunlusoy B; Kara C; Arslan M; Ceylan Y; Minareci S
    Urology; 2012 Nov; 80(5):1051-5. PubMed ID: 22995568
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Peyronie's disease: epidemiology, diagnosis, and management.
    Miner MM; Seftel AD
    Curr Med Res Opin; 2014 Jan; 30(1):113-20. PubMed ID: 24040888
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Experience with plaque excision and dermal grafting in the surgical treatment of Peyronie's disease.
    Goyal NK; Kumar A; Das SK; Pandey AK; Sharma GK; Trivedi S; Dwivedi US; Singh PB
    Singapore Med J; 2008 Oct; 49(10):805-8. PubMed ID: 18946615
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Extracorporeal shockwave therapy for Peyronie's disease: an alternative treatment?
    Poulakis V; Skriapas K; de Vries R; Dillenburg W; Ferakis N; Witzsch U; Melekos M; Becht E
    Asian J Androl; 2006 May; 8(3):361-6. PubMed ID: 16625288
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence of Peyronie's disease among patients with erectile dysfunction.
    El-Sakka AI
    Eur Urol; 2006 Mar; 49(3):564-9. PubMed ID: 16386353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peyronie's disease in diabetic patients being screened for erectile dysfunction.
    El-Sakka AI; Tayeb KA
    J Urol; 2005 Sep; 174(3):1026-30. PubMed ID: 16094040
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diabetes mellitus is associated with severe Peyronie's disease.
    Kendirci M; Trost L; Sikka SC; Hellstrom WJ
    BJU Int; 2007 Feb; 99(2):383-6. PubMed ID: 17313425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Safety and efficacy of coenzyme Q10 supplementation in early chronic Peyronie's disease: a double-blind, placebo-controlled randomized study.
    Safarinejad MR
    Int J Impot Res; 2010; 22(5):298-309. PubMed ID: 20720560
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Stereological and biochemical analysis of muscular and connective tissue components in the penile corpus cavernosum adjacent to the fibrous plaque of Peyronie's disease.
    Costa WS; Rebello SB; Cardoso LE; Cavalcanti AG; Sampaio FJ
    BJU Int; 2009 Jan; 103(2):212-6. PubMed ID: 18782314
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical approaches for advanced Peyronie's disease patients.
    Hellstrom WJ; Usta MF
    Int J Impot Res; 2003 Oct; 15 Suppl 5():S121-4. PubMed ID: 14551588
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Replacement of plaque by buccal mucosa in the treatment of Peyronieś disease: a report of 27 cases].
    Liu B; Zhu XW; Zhong DC; Shen BH; Jiang H; Xie LP
    Zhonghua Nan Ke Xue; 2009 Jan; 15(1):45-7. PubMed ID: 19288749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical efficacy of collagenase Clostridium histolyticum in the treatment of Peyronie's disease by subgroup: results from two large, double-blind, randomized, placebo-controlled, phase III studies.
    Lipshultz LI; Goldstein I; Seftel AD; Kaufman GJ; Smith TM; Tursi JP; Burnett AL
    BJU Int; 2015 Oct; 116(4):650-6. PubMed ID: 25711400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Medium-term follow-up of plaque incision and porcine small intestinal submucosal grafting for Peyronie's disease.
    Staerman F; Pierrevelcin J; Ripert T; Menard J
    Int J Impot Res; 2010; 22(6):343-8. PubMed ID: 21124338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Vein grafting of tunical incisions in the treatment of Peyronie's disease.
    Chalouhy E; Kassardjian Z; Abi Moussa M; Ayoub N; Merhej S; Moukarzel M; el Khoury R
    J Med Liban; 1998; 46(5):251-5. PubMed ID: 10349258
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nonpalpable scarring of the penile septum as a cause of erectile dysfunction: an atypical form of Peyronie's disease.
    Bella AJ; Sener A; Foell K; Brock GB
    J Sex Med; 2007 Jan; 4(1):226-230. PubMed ID: 17034410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of Peyronie's disease. What does our clinical experience show?
    Casabé A; Bechara A; Cheliz G; De Bonis W; Rey H
    J Sex Med; 2011 Feb; 8(2):518-23. PubMed ID: 20955309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.